This is a non-core endpoint: only basic statistics are computed.
Use of memantine
ADMED_MEMANTINE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
N06DX01
1 out of 7 registries used, show all original rules.
6358
Check minimum number of events
Min. number of events
3
6358
Include endpoints None
6358
Remove individuals based on genotype QC
6133
ADMED_MEMANTINE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Use of memantine
based on the number of shared cases.
Broader endpoints:
- Use of other anti-dementia drugs
- Alzheimer’s disease, wide definition (more control exclusions)
- Alzheimer’s disease, wide definition
- Dementia
- Dementia, including avohilmo
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6133 | 2708 | 3425 |
| Unadjusted prevalence (%) | 1.63 | 1.28 | 2.06 |
| Mean age at first event (years) | 79.77 | 79.88 | 79.68 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ADMED_MEMANTINE – Use of memantine
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of memantine
↥Endpoint not on priority list, no data to show.